However, while TGF-β may inhibit the growth of mammary tumors in the early stages, it also appears, in these models, to enhance the metastatic potential of those carcinomas that are able to overcome the TGF-β-dependent growth suppression and develop. Here, TGFB1 is linked to carcinoma.